Publications and Presentations Featuring Spero Therapeutics Drug Candidates and Research

Browse through key publications and presentations that have discussed our drug candidates and our work involving the treatment of bacterial infections.

Presentation Categories

Oral 6
Poster 86
Written 13
Select All

Hospital Costs and Reimbursement in Patients with Resistant Enterobacteriaceae (ENT) Urinary Tract Infection (UTI) in the United States (US): A Multicenter Analysis

October 27, 2020

Hospital Admission Patterns in Adult Patients with Complicated Urinary Tract Infections: Identification of Potentially Avoidable Hospital Admissions Across US Hospitals

October 27, 2020

Epidemiology of Complicated Urinary Tract Infections ( cUTIs ) Presenting in Emergency Departments Across the United States (US)

October 27, 2020

Oral Tebipenem Pivoxil Hydrobromide is Non-inferior to IV Ertapenem in Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) – Results from the Pivotal ADAPT-PO Study

October 27, 2020

Advancement of GyrB Inhibitors for Treatment of Infections Caused by Mycobacterium tuberculosis and Non-tuberculous Mycobacteria

March 17, 2020

ACS Infect. Dis. https://doi.org/10.1021/acsinfecdis.0c00025 Suzanne S. Stokes, Rajender Vemula, Michael J. Pucci

Pages: 12345678910111213141516171819202122232425

Publications and Presentations Featuring Spero Therapeutics Drug Candidates and Research

Presentation Categories

Presentation Tags